These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31902143)

  • 1. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
    Suh S; Kim KW
    Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
    Biadgo B; Abebe M
    Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study.
    Kuo SC; Lai SW; Hung HC; Muo CH; Hung SC; Liu LL; Chang CW; Hwu YJ; Chen SL; Sung FC
    J Diabetes Complications; 2015; 29(8):1071-6. PubMed ID: 26233574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.
    Onitilo AA; Engel JM; Glurich I; Stankowski RV; Williams GM; Doi SA
    Cancer Causes Control; 2012 Jul; 23(7):991-1008. PubMed ID: 22527174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Type 2 Diabetes and Site-Specific Cancers: Linking Mechanisms.
    Hosseini L; Alinezhad F; Kharazi U; Badalzadeh R
    Crit Rev Oncog; 2019; 24(3):259-267. PubMed ID: 32422024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus: influences on cancer risk.
    Szablewski L
    Diabetes Metab Res Rev; 2014 Oct; 30(7):543-53. PubMed ID: 25044584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urolithiasis: a link between stone formation and diabetes mellitus?
    Zimmerer T; Weiss C; Hammes HP; Braun C; Hesse A; Alken P; Knoll T
    Urol Int; 2009; 82(3):350-5. PubMed ID: 19440027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone disorders associated with diabetes mellitus and its treatments.
    Cortet B; Lucas S; Legroux-Gerot I; Penel G; Chauveau C; Paccou J
    Joint Bone Spine; 2019 May; 86(3):315-320. PubMed ID: 30098423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms.
    Zhu B; Qu S
    Front Endocrinol (Lausanne); 2022; 13():800995. PubMed ID: 35222270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
    Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
    Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
    Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
    Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.